Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Trading Update

13 Jan 2016 07:00

RNS Number : 6641L
Ted Baker PLC
13 January 2016
 

13 January 2016

 

Ted Baker Plc

("Ted Baker" or the "Group")

Trading Update

For the 8 week period from 15 November 2015 to 9 January 2016

"Good retail performance over the Christmas period"

Ted Baker, the global lifestyle brand, is pleased to announce a 10.1% (10.6% constant currency) increase in retail sales for the 8 week period from 15 November 2015 to 9 January 2016 (the "period"), compared to the equivalent dates last year. Average retail square footage rose by 7.5% over the period to 355,907 sq.ft. (2015: 331,208 sq.ft.)

 

Gross margins were in line with expectations and there was no significant promotional activity before Christmas. We expect to end the year with a clean stock position.

 

Expansion continued during the period with additional concessions in the UK, France and Spain and a new store opening in California. Licence partner openings included a new outlet in each of Melbourne and Sydney, a new store in Saudi Arabia and a new concession in Mexico.

 

Our e-commerce business performed well, with sales increasing 39.1% reflecting a good performance across all of the Group's websites.

 

We continue to invest for the long-term development of the Ted Baker brand and this result reflects a good performance generally across our markets.

 

We intend to announce our Annual Results for the 52 weeks ending 30 January 2016 on 17 March 2016 and the Board anticipates that results will be in line with its expectations.

 

Commenting on trading, Ray Kelvin CBE, Founder and Chief Executive said:

 

"The Ted Baker brand has performed well over the Christmas period against a tough trading backdrop. We continue to invest across international markets for the further development of Ted Baker as a global lifestyle brand.

 

Commitment to quality, design and attention to detail underpins everything we do, as well as the talent, passion and Tedication of our team. On behalf of the Board I would like to thank everyone across the world for their continued hard work."

 

Ted Baker

Tel: +44 (0) 20 7255 4800

Ray Kelvin CBE, Founder & Chief Executive

 

Lindsay Page, Chief Operating Officer & Group Finance Director

 

Charles Anderson, Finance Director & Company Secretary

 

 

 

Hudson Sandler

Tel: +44 (0) 20 7796 4133

Alex Brennan / Michael Sandler / Jessica Reid

 

 

Enquiries and further information:

www.tedbaker.com

www.tedbakerplc.com

 

Media images available for download at:

www.tedbakerplc.com/ted/en/mediacentre/imagelibrary

 

Cautionary statement regarding forward-looking statements

This announcement contains certain forward-looking statements. These forward-looking statements include matters that are not historical facts or are statements regarding the Group's intentions, beliefs or current expectations concerning, among other things, the Group's results of operations, financial condition, liquidity, prospects, growth, strategies, and the industries in which the Group operates.

Forward-looking statements are based on the information available to the Directors at the time of preparation of this announcement, and will not be updated. The Directors can give no assurance that these expectations will prove to have been correct. Due to inherent uncertainties, including both economic and business risk factors underlying such forward looking information, actual results may differ materially from those expressed or implied by these forward-looking statements.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMMGMMLZLGVZM
Date   Source Headline
18th Mar 20228:20 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSStatement re Possible Offer
7th Mar 20221:01 pmRNSHolding(s) in Company
23rd Feb 20227:00 amRNSQ4 2022 / Pre-close trading update
17th Dec 20213:04 pmRNSBoard composition
6th Dec 20217:00 amRNSJohn Barton
1st Dec 20214:56 pmRNSTotal Voting Rights
11th Nov 202110:48 amRNSReplacement Interim Results
11th Nov 20217:00 amRNSInterim Results
5th Nov 202112:04 pmRNSDirectorate Change
2nd Nov 20213:13 pmRNSBlock listing Interim Review
6th Oct 20214:17 pmRNSDirector/PDMR Shareholding
4th Oct 20217:00 amRNSNew Joint Broker
7th Sep 20217:00 amRNSQ2 Trading Update
4th Aug 20217:00 amRNSDirectorate Change
3rd Aug 202111:22 amRNSDirector/PDMR Shareholding
28th Jul 20213:12 pmRNSNotice of Results
28th Jul 20217:00 amRNSNotice of Q2 Trading Update
23rd Jul 20217:00 amRNSNew Global HQ
28th Jun 20217:00 amRNSNotice of AGM
17th Jun 20217:00 amRNSHolding(s) in Company
14th Jun 20217:00 amRNSFinal Results
9th Jun 20213:11 pmRNSChange to Full Year Results Date
25th May 20217:00 amRNSSuccessful bank refinancing
24th May 20217:00 amRNSChange to Full Year Results Date
13th May 20217:00 amRNSHolding(s) in Company
6th May 20212:54 pmRNSBlock listing Interim Review
29th Apr 202110:55 amRNSHolding(s) in Company
11th Mar 20217:00 amRNSTed Baker announces new territory licence deals
24th Feb 202112:30 pmRNSAdditional Listing
11th Feb 20217:00 amRNSNotice of Results
4th Feb 202110:01 amRNSTotal Voting Rights
8th Jan 20213:47 pmRNSNotice of Results
16th Dec 20206:35 pmRNSDirector/PDMR Shareholding
7th Dec 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSChange to Interim Results Date
3rd Nov 20205:07 pmRNSBlock listing Interim Review
2nd Nov 202011:49 amRNSHolding(s) in Company
26th Oct 202010:50 amRNSDirector/PDMR Shareholding
14th Oct 202011:31 amRNSNotice of Results
7th Oct 20204:56 pmRNSHolding(s) in Company
6th Oct 20202:34 pmRNSTotal Voting Rights
30th Sep 202010:17 amRNSDirector/PDMR Shareholding
4th Sep 20202:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20204:26 pmRNSDirector/PDMR Shareholding
1st Sep 202010:10 amRNSDirectorate Change
18th Aug 20205:13 pmRNSDirector/PDMR Shareholding
4th Aug 202011:58 amRNSTotal Voting Rights
24th Jul 20205:54 pmRNSHolding(s) in Company
21st Jul 202012:17 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.